Wednesday, 22 October 2014
Last updated 18 sec ago
Dec 7 2011 | 10:11am ET
A former Galleon Group trader has signed a deal to write a memoir that will focus heavily on his relatively brief stint at the hedge fund brought down by insider-trading.
Turney Duff will receive more than $250,000 to write The Buy Side, which will cover the 41-year-old's entire career with a significant chunk dealing with his two years at Galleon, from 1999 until 2001. Crown Business, the publisher, describes the book as "a journey through the trading underworld as well as a look at after-hours Wall Street, where sex and drugs are the quid pro quo in a culture in which a billion isn't enough."
The book deal for Duff comes as his old boss, Galleon founder Raj Rajaratnam, begins his 11-year prison sentence for insider trading. Rajaratnam was convicted in May and reported to prison on Monday.
Duff was not implicated in any of Rajaratnam's illegal dealings.
The Buy Side is due in 2013.
Duff was a health care trader at Galleon, which he joined from Morgan Stanley. He left the hedge fund to co-found Argus Partners and joined hedge fund J.L. Berkowitz & Co. in 2007. He left that firm in 2009, in part to pursue his new career as a writer.
Sep 22 2014 | 4:15pm ET
"I tell people that everybody likes good news and so if you have good performance that’s wonderful,” explains Mike McKitish of Peddie School's endowment, “but it’s the people that want to talk about the bad news or where they drifted and how they came back and how they stayed to their discipline…” that he wants to hear from. Read more…
Sep 30 2014 | 9:29am ET
The crisp Autumnal days of October are upon us, and so are a few of the hedge fund industry’s favorite charitable events. If you have never been to Rocktoberfest, well, you are missing out. And for a quieter evening of sipping and socializing, stop by HFC’s Wine Soiree. Read more…
Most traders agree that proper risk management is the key to successful trading. However, many traders depend on the deeply flawed measure of standard deviation as a benchmark of risk. Here we put it ...